Professionally Psychedelics Podcast – Christian Angermayer, atai Life Sciences & Apeiron Investment Group

Christian Angermayer - atai Life Sciences - Apeiron Investment Group - Compass Pathways - Professionally Psychedelics Podcast - GCI Content Hub

As the lead investor in Compass Pathways, Founder of Atai Life Sciences and Apeiron Investment Group, Christian Angermayer is the perfect person to talk everything psychedelics in 2022.

With a diverse portfolio across Fintech, Crypto, Life Sciences, Media, Entertainment and more, Christian is a true leader in spotting unique business opportunities and driving these organisations forward. Tune into Christian’s interview today!

Check out other podcasts on the GCI Content Hub by clicking here.

Previous articleStudy Maps Neurological Sources of Subjective Psychedelic Experiences
Next articleGovernment of Rwanda Assigns Land for Medical Cannabis Production